Hepatic cholesterol-lipid anomalies induced by aflatoxin.
D000348:Aflatoxins / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight; D002784:Cholesterol / Q000032:analysis*; D004372:Ducks; D005260:Female; D008041:Linoleic Acids / Q000032:analysis; D008055:Lipids / Q000032:analysis*; D008099:Liver / Q000032:analysis / Q000187:drug effects*; D008297:Male; D008859:Microscopy, Polarization; D009829:Oleic Acids / Q000032:analysis; D009929:Organ Size; D010169:Palmitic Acids / Q000032:analysis; D013229:Stearic Acids / Q000032:analysis; D013997:Time Factors; D014280:Triglycerides / Q000032:analysis
D000348:Aflatoxins; D008041:Linoleic Acids; D008055:Lipids; D009829:Oleic Acids; D010169:Palmitic Acids; D013229:Stearic Acids; D014280:Triglycerides; D002784:Cholesterol